1. The biological roles of CD24 in ovarian cancer: old story, but new tales
   Yuanyuan Gu et al, 2023, Frontiers in Immunology CrossRef
2. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment
   Weranga Rajapaksha et al, 2024, Frontiers in Drug Delivery CrossRef
3. A Comparative in Silico Analysis of CD24’s Prognostic Value in Human and Canine Prostate Cancer
   Antonio Fernando Leis-Filho et al, 2021, Journal of Personalized Medicine CrossRef
4. CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights
   Sherri L Christian, 2022, OncoTargets and Therapy CrossRef
5. Lipid-based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review
   Mehrdad Moosazadeh Moghaddam et al, 2022, Current Drug Delivery CrossRef
6. Potential of green-synthesized ZnO NPs against human ovarian teratocarcinoma: an in vitro study
   Mohd Shahnawaz Khan et al, 2023, Molecular Biology Reports CrossRef